Images
![Granisetron (transdermal) (Granisetron (transdermal) [ gra-nis-e-tron ])-93 7485-1 mg-White-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/07/13/granisetron-5ht3-receptor-antagonists-93-7485-1-mg-white-capsule-shape-3501762-4170.webp "93 7485 Pill - white capsule-shape, 9mm")
![Granisetron (transdermal) (Granisetron (transdermal) [ gra-nis-e-tron ])-93 7485-1 mg-White-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/07/13/granisetron-5ht3-receptor-antagonists-93-7485-1-mg-white-capsule-shape-3501762-4171.webp "93 7485 Pill - white capsule-shape, 9mm")
![Granisetron (transdermal) (Granisetron (transdermal) [ gra-nis-e-tron ])-93 7485-1 mg-White-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/07/13/granisetron-5ht3-receptor-antagonists-93-7485-1-mg-white-capsule-shape-3501762-4172.webp "93 7485 Pill - white capsule-shape, 9mm")
Granisetron (transdermal) |
|
| Generic Name: | granisetron (transdermal) [ gra-nis-e-tron ] |
| Imprint: | 93 7485 |
| Strength: | 1 mg |
| Color: | White |
| Size: | 9.00 mm |
| Shape: | Capsule-shape |
| Availability: | Prescription only |
| Drug Class: | 5HT3 receptor antagonists |
| Pregnancy Category: | B - No proven risk in humans |
| CSA Schedule: | Not a controlled drug |
| Labeler / Supplier: | N/A |
| National Drug Code (NDC): | 00093-7485 (Discontinued) |
| Inactive Ingredients: | Hypromellose 2910 (3 mPa.s), Hypromellose 2910 (5 mPa.s), Lactose monohydrate, Polyethylene glycol 400, Magnesium stearate, Microcrystalline cellulose, Polysorbate 80, Sodium starch glycolate type A potato, Titanium dioxide, |
